ALK Genomic Aberrations in NSCLC and Clinical Implications

被引：0
|
作者：
Hirsch, F. R. [1 ]
机构：
[1] Mt Sinai, New York, NY USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 11期
关键词：
Crizotinib; Ceritinib; Alectinib; Brigatinib; Lorlatinib; CHEMOTHERAPY; CRIZOTINIB;
D O I：
10.1016/j.jtho.2019.09.114
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
I.17
引用
收藏
页码：S1163 / S1164
页数：3
相关论文
共 50 条
  • [41] ALK status of NSCLC reflected in CTCs
    Vanessa Marchesi
    Nature Reviews Clinical Oncology, 2013, 10 (7) : 366 - 366
  • [42] ALK inhibitors in the treatment of advanced NSCLC
    Gridelli, Cesare
    Peters, Solange
    Sgambato, Assunta
    Casaluce, Francesca
    Adjei, Alex A.
    Ciardiello, Fortunato
    CANCER TREATMENT REVIEWS, 2014, 40 (02) : 300 - 306
  • [43] MET and ALK as Targets for the Treatment of NSCLC
    Capelletti, M.
    Gelsomino, F.
    Tiseo, M.
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (24) : 3914 - 3932
  • [44] ALK Inhibitor and Chemotherapy Combinations in Models of ALK-Translocated NSCLC
    Luukkainen, Milla E. k
    Koivunen, Jussi P.
    ANTICANCER RESEARCH, 2024, 44 (07) : 2805 - 2813
  • [45] ALK plus NSCLC ALK Inhibitors symbolize Progress in Cancer Medicine
    Kohl, Angelika
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (7-8) : 435 - 435
  • [46] A Novel Nonreciprocal/Reciprocal ALK Translocation Cause ALK plus in NSCLC
    Chen, Xianguo
    Xu, Bo
    Fu, Fangni
    Cai, Ke
    Yu, Zhaonan
    LUNG CANCER, 2021, 158 : 162 - 163
  • [47] Clinical diagnosis of EML4-ALK mutation in NSCLC by a gold nanoparticle beacon
    Liu, Yuxi
    Li, Siwen
    Chen, Dan
    Wang, Zhaohui
    Zhang, Jinnan
    Tian, Caiping
    Ding, Li
    Chen, Yaqi
    Qian, Zhiyu
    Gu, Yueqing
    RSC ADVANCES, 2016, 6 (104) : 102398 - 102405
  • [48] Clinical Characteristics of EML4-ALK Positive and Surgically Resected NSCLC Patients
    Tao, Hong
    Cai, Yiran
    Liu, Zhe
    Shi, Liang
    Tang, Junfang
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S670 - S671
  • [49] Description of ALK plus NSCLC patient characteristics and ALK testing patterns
    Wakelee, Heather A.
    Sasane, Medha
    Zhang, Jie
    Macalalad, Alexander R.
    Galebach, Philip J.
    Jarvis, John
    Kageletry, Andrew James
    Huang, Qing
    Culver, Kenneth W.
    Wu, Eric Qiong
    Guerin, Annie
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [50] Description of ALK plus NSCLC Patient Characteristics and ALK Testing Patterns
    Wakelee, H. A.
    Sasane, M.
    Zhang, J.
    Macalalad, A. R.
    Galebach, P.
    Jarvis, J.
    Kageleiry, A.
    Huang, Q.
    Culver, K.
    Wu, E. Q.
    Guerin, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S60 - S61
12345